DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY (DLDD) | |
DLD DEFICIENCY; E3 DEFICIENCY; MSUD TYPE III | |
246900
OMIM = Online Mendelian Inheritance of Men | |
2394 | |
Dihydrolipoyl dehydrogenase, mitochondrial | |
1.8.1.4 | |
7q31.1 |
|
E74.4 | |
very rare (<1:1000000) autosomal recessive mutation in the DLD gene antiepileptic drugs (valproate and topiramate) resulted in a profile that mimicked PDH (E3) [Mampilly GT et al. 2014] | |
Laboratory findings | 2-Oxoadipic acid inc (urine) Citrulline inc (plasma) 2-Oxoglutaric acid inc (urine) L-Lactic acid inc (urine) Ammonia inc (blood) D-Glucose normal/dec (blood) L-Isoleucine inc (plasma) L-Lactic acid inc (blood) Lactate/Pyruvate ratio inc (blood) Leucine inc (plasma) Pyruvic acid inc (blood) Sedoheptulose-7-phosphate inc (urine) Valine inc (plasma) |
Symptoms | hyperammonemia hypoglycemia lactic acidosis ataxia basal ganglia, changes, lesions, calcifications (MRI, CT) cardiomyopathy cardiomyopathy, hypertrophic cortical or cerebral atrophy developmental delay dystonia early death encephalopathy failure to thrive feeding difficulties, poor feeding growth retardation, poor growth hepatomegaly (large liver) intracerebral, cortical or paraventricular cysts Leigh syndrome liver failure liver involvement or dysfunction mental retardation metabolic acidosis microcephaly (<2 SD for age) motor retardation muscle weakness onset, infancy onset, neonatal Organic acids, urine seizures stridor tachypnea, hyperpnea, dyspnea, hyperventilation vomiting |